Replies to post #142502 on PharmaCyte Biotech Inc (PMCB)

[oldmusky]

"Nasdaq is requiring the Company to trade above $4.00 for 10 trading days before we can uplist.”

This is a true statement. But it is SO misleading to shareholders.

I spent two hours going over the Nasdaq requirements in specificity.

There is no way this company qualifies for the Nasdaq. PharmaCyte does not meet the requirements.

Just trading over $4.00 for ten days is one requirement. The company has had 0 revenue for a long time.

Their assets are small.

The Nasdaq requires strong management and sound reputation. I will certainly come back and eat crow if I am wrong but the way I understand it , No way does PMCB qualify for the Nasdaq and it's not even close.

I believe management is getting bolder in misleading shareholders when they say we are going to be listed on the Nasdaq.

This is all just one educated persons opinion.

[$Pistol Pete$]

OMG….now Nasdaq promising on this scam….no way Nasdaq with zero dollar revenue…..too funny

[thenewmixer]

NASDAQ by April 15th